Fermenta Biotech Limited (BOM:506414)

Market Cap	8.55B +10.9%
Revenue (ttm)	5.48B +16.7%
Net Income	717.65M -6.6%
EPS	24.51 -7.0%
Shares Out	29.43M
PE Ratio	11.86
Forward PE	n/a
Dividend	2.50 (0.86%)
Ex-Dividend Date	Aug 6, 2025

Volume	4,373
Open	287.55
Previous Close	290.60
Day's Range	287.50 - 296.35
52-Week Range	256.40 - 399.00
Beta	-0.18
Analysts	n/a
Price Target	n/a
Earnings Date	May 26, 2026

About Fermenta Biotech

Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It provides pharmaceutical formulations and environmental solutions; rents and sells properties; and sports and health awareness/education services. The company also offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder for use in various applications, such as pharmaceuticals, dietary and nutritional sup...

• Industry: Pharmaceutical Preparations
• Founded: 1951
• Employees: 606
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506414

Financial Performance

In fiscal year 2026, Fermenta Biotech's revenue was 5.48 billion, an increase of 16.69% compared to the previous year's 4.69 billion. Earnings were 717.65 million, a decrease of -6.63%.